Clinical Trial Update: Observation in Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Treated on Clinical Trial CAN-NCIC-LY9

View source ↗

Summary

Clinical trial update reporting observational data from patients with diffuse large B-cell lymphoma treated on CAN-NCIC-LY9. The current study status is listed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Snippet

Sponsor: German High-Grade Non-Hodgkin's Lymphoma Study Group | Conditions: Long-term Effects Secondary to Cancer Therapy in Adults, Lymphoma | Status: UNKNOWN